Hevilla, F.; Porras, N.; Girón, M.V.; GarcÃa-Olivares, M.; Padial, M.; Sánchez-Torralvo, F.J.; Olveira, C.; Olveira, G.
Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study. Nutrients 2024, 16, 3293.
https://doi.org/10.3390/nu16193293
AMA Style
Hevilla F, Porras N, Girón MV, GarcÃa-Olivares M, Padial M, Sánchez-Torralvo FJ, Olveira C, Olveira G.
Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study. Nutrients. 2024; 16(19):3293.
https://doi.org/10.3390/nu16193293
Chicago/Turabian Style
Hevilla, Francisco, Nuria Porras, MarÃa Victoria Girón, MarÃa GarcÃa-Olivares, Marina Padial, Francisco José Sánchez-Torralvo, Casilda Olveira, and Gabriel Olveira.
2024. "Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study" Nutrients 16, no. 19: 3293.
https://doi.org/10.3390/nu16193293
APA Style
Hevilla, F., Porras, N., Girón, M. V., GarcÃa-Olivares, M., Padial, M., Sánchez-Torralvo, F. J., Olveira, C., & Olveira, G.
(2024). Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on Body Composition, Dietary Intake, Biomarkers, and Quality of Life in People with Cystic Fibrosis: A Prospective Observational Study. Nutrients, 16(19), 3293.
https://doi.org/10.3390/nu16193293
